Bosh sahifaFBIOP • NASDAQ
add
Fortress Biotech 9 375 Cumulative Redeemable Perpetual Pref Shs Series A
Yopilish kursi
5,18 $
Kunlik diapazon
5,15 $ - 5,30 $
Yillik diapazon
4,86 $ - 18,00 $
Bozor kapitalizatsiyasi
44,14 mln USD
Oʻrtacha hajm
21,26 ming
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 14,63 mln | -7,13% |
Joriy xarajat | 21,99 mln | 1,20% |
Sof foyda | -12,87 mln | -155,04% |
Sof foyda marjasi | -87,96 | -174,62% |
Har bir ulushga tushum | -0,76 | 19,15% |
EBITDA | -21,14 mln | 33,04% |
Amaldagi soliq stavkasi | -0,26% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 58,85 mln | -18,61% |
Jami aktivlari | 127,08 mln | -15,59% |
Jami passivlari | 139,82 mln | -14,63% |
Umumiy kapital | -12,74 mln | — |
Tarqatilgan aksiyalar | 27,60 mln | — |
Narxi/balansdagi bahosi | 6,73 | — |
Aktivlardan daromad | -40,50% | — |
Kapitaldan daromad | -83,30% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -12,87 mln | -155,04% |
Operatsiyalardan naqd pul | -20,06 mln | -19,55% |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | 2,71 mln | 200,97% |
Naqd pulning sof oʻzgarishi | -17,35 mln | -19,93% |
Boʻsh pul | -11,24 mln | 25,59% |
Haqida
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
Tashkil etilgan
2006
Xodimlar soni
186
